Krystal Biotech is upgraded to Strong Buy as Vyjuvek sales surge and catalysts build. Click here to know more.
Zacks Investment Research on MSN
Implied volatility surging for Vertex Pharmaceuticals stock options
Investors in Vertex Pharmaceuticals Incorporated VRTX need to pay close attention to the stock based on moves in the options ...
24/7 Wall St. on MSN
Triple-leveraged biotech ETF doubles as regulatory winds shift in 2026
Quick Read Direxion Biotech Bull 3X (LABU) doubled over the past year by delivering three times the daily biotech index ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback